Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 001
mi
from
Bradenton, FL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 001
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 064
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 061
mi
from
Orlando, FL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 032
mi
from
West Palm Beach, FL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 032
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Atlanta, GA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 276
mi
from
Decatur, GA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 276
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 016
mi
from
Berlin, NJ
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 016
mi
from
Berlin, NJ
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 023
mi
from
Cherry Hill, NJ
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 023
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Albuquerque, NM
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 011
mi
from
Bronx, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 011
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 051
mi
from
Brooklyn, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 051
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 051
mi
from
Brooklyn, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 051
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 008
mi
from
Cedarhurst, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 008
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 037
mi
from
Mount Kisco, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 037
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative site 026
mi
from
Dayton, OH
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative site 026
mi
from
Dayton, OH
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Portland, OR
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 054
mi
from
Allentown, PA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 054
mi
from
Allentown, PA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 010
mi
from
Media, PA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 010
mi
from
Media, PA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Memphis, TN
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Dallas, TX
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site 012
mi
from
Herndon, VA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site 012
mi
from
Herndon, VA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site
mi
from
Bellevue, WA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  10/29/2013
Forest Investigative Site #027
mi
from
Seattle, WA
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 10/29/2013
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site
mi
from
Phoenix, AZ
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 109
mi
from
Imperial, CA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 109
mi
from
Imperial, CA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 021
mi
from
San Francisco, CA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 021
mi
from
San Francisco, CA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 073
mi
from
Santa Ana, CA
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 073
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 037
mi
from
Boulder, CO
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 037
mi
from
Boulder, CO
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 073
mi
from
Centennial, CO
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 073
mi
from
Centennial, CO
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 29
mi
from
Hartford, CT
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 29
mi
from
Hartford, CT
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 008
mi
from
Washington,
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 008
mi
from
Washington,
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 135
mi
from
Destin, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 135
mi
from
Destin, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 064
mi
from
Gainesville, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 064
mi
from
Gainesville, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 122
mi
from
Gulf Breeze, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 122
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 1854
mi
from
Hialeah, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 1854
mi
from
Hialeah, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site #029
mi
from
Maitland, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site #029
mi
from
Maitland, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 085
mi
from
Oakland Park, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 085
mi
from
Oakland Park, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative site 067
mi
from
Miami, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative site 067
mi
from
Miami, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 101
mi
from
Wellington, FL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 101
mi
from
Wellington, FL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 023
mi
from
Naperville, IL
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 023
mi
from
Naperville, IL
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site 123
mi
from
Fort Wayne, IN
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site 123
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated:  10/31/2013
Forest Investigative Site
mi
from
Indianapolis, IN
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Previously Treated With Memantine
Status: Enrolling
Updated: 10/31/2013
Forest Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials